Our reports are designes to be easy to read, with sections that allow the identification os the entire process on a single page. Since we began operations, our nomenclature identifies the cases per year, followed by a five-digit case number.
All cases are identified with the full name os the patient and their personal identification number, as required within our country's territory, that is a personal identification card or passport numbers.
The origin of the cases can be viewed as the name of the clinic that sends us the specimen and the care provider's name. W do not use only the name of the provider, because one same physician can refer us cases from two different clinics, and each clinics can have several physicians on staff.
In all cases, the date of receipt of the cases is recorded, which may or may not be the date of sampling. We have chosen this date because it marks our responsability to the patient from this date forward. We cannot be held responsible for a case that has not reached our lab.
In the case of cervical and vaginal cytologies, it's specified whether it's a conventional preparation, a liquid-based preparation or both.
The Bethesda System 2011 also includes anal, conventional, liquid-based or both, in cases of patients requiring this study.
We have designed reports with colored bands to facilitate the interpretation of results based on the risk of developing cancer. Green for cases without risk, yellow for cases with low risk, orange for cases with moderate risk and red for cases with high risk.
Cytologies are not diagnostic test, but screening ones, so any abnormal result, that is that does not have a green band, requires a new cell sample or confirmation biopsy.